🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

0.8 mL Serving Size
74 Servings
Other Combinations Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

1.5 mg (88% DV)
✅ 1.2× RDA — within safe limits 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 1.5mg UL 100mg
1.5 mg
📊 Market median: 3.0mg (984 products) 📚 236 studies (Tier A: 2, B: 109)
This product: 1.5mg UL 10mg

Other Ingredients

Water, Deionized Glycerin Soy Lecithin Orange Flavor, Natural Potassium Sorbate Ascorbic Acid Sodium Citrate Grapefruit Seed Extract Stevia

Label Claims — Verification

All Other
Structure/Function
All Other (100% of products) Structure/Function (86% of products) Nutrient (7% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

As a dietary supplement, use 30 minutes before bedtime, 5 sprays under the tongue, hold 20 seconds, then swallow, or as directed by a healthcare professional. Shake well before use.

⚠️ Warnings & Precautions

Caution: Do not operate any motor vehicles for at least 8 hours after dosage. Do not use if neck wrap is broken or missing.

If pregnant or breast-feeding, ask a healthcare professional before use.

Keep out of reach of children.

Contains soy.

🧪 Formulation Notes

Hormonal support Liquid form for optimal assimilation

Additional Information

Store at room temperature out of direct sunlight.

Product Details

UPC / SKU 3 64578 10015 0
DSLD Entry Date 2025-07-24
Product Type Other Combinations
Form Liquid
Brand Energetix
DSLD ID 333087
Data Updated 2026-04-11

Research Evidence

291 Research Sources
55 Avg Quality Score
129 Meta Analysis
93 Systematic Review
51 Rct
11 Clinical Trial
2 Other
2 Regulatory Source
1 Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021
View all evidence for Melatonin →

Compare Similar Products

View all Melatonin products →